NCT03772834View on ClinicalTrials.gov

Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 25, 2019

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Prostate Carcinoma
Interventions
BEHAVIORAL

Exercise Intervention

Undergo resistance training and walking

DRUG

Methylphenidate

Given PO

OTHER

Placebo

Given PO

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Stretching

Undergo stretching

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT03772834 - Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter